Deutsche Bank Ag\ Cytom X Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.53 - $2.89 $58,361 - $110,239	-38,145 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.67 - $4.68 $11,155 - $19,553	-4,178 Reduced 9.87%	38,145 $102,000
Q4 2021 Feb 11, 2022	BUY	$3.87 - $7.39 $9,574 - $18,282	2,474 Added 6.21%	42,323 $183,000
Q3 2021 Nov 04, 2021	SELL	$4.32 - $6.43 $2,855 - $4,250	-661 Reduced 1.63%	39,849 $203,000
Q2 2021 Aug 11, 2021	SELL	$6.33 - $9.91 $5,336 - $8,354	-843 Reduced 2.04%	40,510 $257,000
Q1 2021 May 13, 2021	SELL	$6.6 - $9.0 $303,441 - $413,784	-45,976 Reduced 52.65%	41,353 $319,000
Q4 2020 Feb 16, 2021	SELL	$6.47 - $7.9 $191,285 - $233,563	-29,565 Reduced 25.29%	87,329 $572,000
Q3 2020 Nov 12, 2020	BUY	$6.55 - $8.83 $366,852 - $494,550	56,008 Added 91.99%	116,894 $777,000
Q2 2020 Aug 13, 2020	BUY	$7.4 - $14.64 $55,529 - $109,858	7,504 Added 14.06%	60,886 $507,000
Q1 2020 May 14, 2020	SELL	$3.61 - $8.6 $449,145 - $1.07 Million	-124,417 Reduced 69.98%	53,382 $410,000
Q4 2019 Feb 14, 2020	SELL	$5.17 - $8.91 $103,911 - $179,082	-20,099 Reduced 10.16%	177,799 $1.48 Million
Q3 2019 Nov 14, 2019	SELL	$7.38 - $12.25 $630,340 - $1.05 Million	-85,412 Reduced 30.15%	197,898 $1.46 Million
Q2 2019 Aug 14, 2019	BUY	$9.35 - $11.41 $2.16 Million - $2.64 Million	231,479 Added 446.6%	283,310 $3.18 Million
Q1 2019 May 15, 2019	BUY	$9.5 - $19.16 $242,734 - $489,557	25,551 Added 97.23%	51,831 $554,000
Q4 2018 Feb 14, 2019	SELL	$12.69 - $18.61 $2.22 Million - $3.26 Million	-175,028 Reduced 86.95%	26,280 $395,000
Q3 2018 Dec 21, 2021	BUY	$18.04 - $26.41 $1.63 Million - $2.39 Million	90,497 Added 81.67%	201,308 $3.73 Million
Q3 2018 Nov 14, 2018	BUY	$18.04 - $26.41 $286,619 - $419,602	15,888 Added 16.74%	110,811 $2.05 Million
Q2 2018 Apr 21, 2020	BUY	$21.38 - $29.68 $407,566 - $565,789	19,063 Added 25.13%	94,923 $2.17 Million
Q2 2018 Aug 14, 2018	SELL	$21.38 - $29.68 $173,691 - $241,120	-8,124 Reduced 9.67%	75,860 $1.73 Million
Q1 2018 Oct 18, 2019	BUY	$21.76 - $34.22 $1.08 Million - $1.69 Million	49,531 Added 143.76%	83,984 $2.39 Million
Q1 2018 May 15, 2018	SELL	$21.76 - $34.22 $807,644 - $1.27 Million	-37,116 Reduced 51.86%	34,453 $978,000
Q4 2017 Feb 14, 2018	SELL	$19.0 - $23.09 $2.41 Million - $2.93 Million	-126,762 Reduced 63.91%	71,569 $1.51 Million
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $2.68 Million - $3.6 Million	198,331	198,331 $3.6 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

49.4M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$6.56 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$4.39 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$4.34 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$4.04 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$2.6 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account